CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended				12 Months Ended
	Jun. 30, 2013		Jun. 30, 2012		Dec. 31, 2012
Cash flows from operating activities
Net loss	$ (4,347,353)		$ (3,152,982)		$ (5,574,775)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	(44,716)		10,521
Depreciation and amortization	71,693		179,647
Stock-based compensation	353,407		549,630
Warrants issued to 2012 private placement investors	487,200
Loss on extinguishment of notes and accounts payable	2,792,900
Imputed value of services contributed	175,000
Amortization of debt discount	84,763		431,422
Changes in operating assets and liabilities:
Accounts receivable	(73,928)		34,386
Inventories - finished goods	37,987		26,878
Prepaid expenses and other current assets	(815)		10,542
Accounts payable - trade	(205,364)		1,120,686
Accounts payable - related parties	159,050		(4,116)
Accrued expenses and other current liabilities	(360,175)		211,438
Deferred revenue	(55,182)
Net cash used in operating activities	(925,533)		(581,948)		(947,911)
Cash flows from investing activities
Change in restricted cash	850,002
Changes in employee advances			138,241
Website development costs	(51,796)
Net cash provided by investing activities	798,206		138,241
Cash flows from financing activities
Principal payments on equipment leases payable	(23,838)		(32,691)
Proceeds from exercise of common stock options			26,662
Proceeds from issuance of notes payable	500,000
Repayment of notes payable	(2,000,000)
Repayment of convertible notes payable	(1,000,000)
Proceeds from the sale of common stock	2,651,973	[1]	175,000	[1]
Cash overdraft			(46,313)
Proceeds from notes payable and other advances - related parties			605,000
Repayment of notes payable and other advances - related parties			(283,812)
Net cash provided by financing activities	128,135		443,846
Net increase in cash	808		139
Cash - beginning of year			40		40
Cash - end of year	808		179
Interest	399,374		21,491
Taxes	899
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	261,084		244,001
Cashless exercise of warrants into common stock	9,734		1,465
Cashless exercise of options into common stock			93
Warrants issued as debt discount in connection with notes payable	315,300
Accrual of contractual dividends on Series B convertible preferred stock	139,680		130,542
Deemed dividends on Series B convertible preferred stock	1,532,722
Reclassification of accounts payable - trade to equipment lease payable			257,583
Deemed dividend - redeemable Series C preferred stock			185,832
Common stock and warrants issued in exchange of notes and accounts payable	$ 3,625,900

[1] Excludes $850,002 of cash received during 2012 but closed on during the six months ended June 30, 2013.